Seppelt, Ian

Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial

Writing Committee for the REMAP-CAP Investigators, Abdelhady, H., Abdelrazik, M., Abdi, Z., Abdo, D., Abdulle, A., Abel, L., Abouzeenni, S., Abrahamson, G., Abusamra, Y., et al. (2021) · JAMA

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 212

The impact of bacterial and viral co‐infection in severe influenza

Blyth, C. C., Webb, S. A. R., Kok, J., Dwyer, D. E., van Hal, S. J., Foo, H., Ginn, A. N., Kesson, A. M., Seppelt, I., Iredell, J. R., et al. (2013) · Influenza and Other Respiratory Viruses

Influenza Virus Research StudiesRespiratory viral infections research

Cited by 117

Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials

The LOVIT-COVID Investigators, O. B. O. T. C. C. C. T. G., Florescu, S., Stanciu, D., Zaharia, M., Kosa, A., Codreanu, D., Fareed, K., Kidwai, A., Kaye, C., Coutts, A., et al. (2023) · JAMA

Vitamin C and Antioxidants ResearchCOVID-19 Clinical Research Studies

Cited by 55

Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients

Gamage, H. K. A. H., Venturini, C., Tetu, S. G., Kabir, M., Nayyar, V., Ginn, A. N., Roychoudhry, B., Thomas, L., Brown, M., Holmes, A., et al. (2021) · Scientific Reports

Gut microbiota and healthAntibiotic Use and Resistance

Cited by 20